Back
Corporate News
Pharmaids Pharmaceuticals to review quarterly results at board meeting on August 12, 2026
06-Aug-2026, 05:04
Pharmaids Pharmaceuticals Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the unaudited financial results (standalone & consolidated) for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited. The company closed its trading window for securities dealings from July 01, 2026, and it will reopen 48 hours after the financial results are declared.
Pharmaids Pharmaceuticals Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the unaudited financial results (standalone & consolidated) for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited. The company closed its trading window for securities dealings from July 01, 2026, and it will reopen 48 hours after the financial results are declared.